Noramco, a leading global active pharmaceutical ingredients (API) manufacturer, specializing in controlled substances, announced today it has completed the acquisition of the Cambrex Drug Product Business Unit previously known as Halo Pharmaceuticals.
Noramco Celebrates Diversity and International Women’s Day
Noramco announced today that its industry-leading cannabinoids business will become a separate company – Purisys, LLC.